66 Tigatuzumab, a novel anti-human death receptor 5 antibody, shows synergistic efficacy against colon cancer in vitro and in vivo in combination with chemotherapy

66 Tigatuzumab, a novel anti-human death receptor 5 antibody, shows synergistic efficacy against colon cancer in vitro and in vivo in combination with chemotherapy

Saved in:
Bibliographic Details
Published in:European journal of cancer supplements Vol. 8; no. 7; p. 29
Main Authors: Yada, A, Ogitani, Y, Ishida, S, Ichikawa, K, Fujiwara, K
Format: Journal Article
Language:English
Published: Elsevier Ltd 2010
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(10)71771-7